Modulatory Effects of Peroxisome Proliferator-Activated Receptor-&ggr; on CXCR3 Chemokines

E-ISSN： 2212-2710|8|2|132-138

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.8, Iss.2, 2014-05, pp. : 132-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

From Dual Peroxisome Proliferator Activated Receptor Agonists to Selective Peroxisome Proliferator Activated Receptor Modulators

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 2, Iss. 1, 2008-01 ,pp. : 24-28

Bentham Science Publishers

Access to resources Recommend Favorite

Isoform Selective Phosphoinositide 3-Kinase amp;#947; and amp;#948; Inhibitors and Their Therapeutic Potential

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 2, Iss. 1, 2008-01 ,pp. : 1-10

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Chemokine (C-X-C motif) Receptor 3 in Thyroid Autoimmunity

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 8, Iss. 2, 2014-05 ,pp. : 95-101

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines as Novel Therapeutic Targets in Autoimmune Thyroiditis

Recent Patents on DNA & Gene Sequences, Vol. 4, Iss. 1, 2010-01 ,pp. : 52-57

Bentham Science Publishers

Access to resources Recommend Favorite

Pleiotropic Effects of Omega-3 Fatty Acids

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 1, 2012-01 ,pp. : 40-46

Bentham Science Publishers

Access to resources Recommend Favorite